梅波利祖马布在严重的喘中具有eosinophilic表型和重叠的严重过敏喘的现实世界的有效性
Jason K Lee1, Stephen J Pollard2, Mark C Liu3
1Toronto Allergists, Evidence Based Medical Educator, Toronto, Ontario, Canada.
概括
梅波利祖马布有效地减少了严重喘患者与eosinophilic表型的恶化,即使是那些重叠过敏特征. 这项实践研究证实了它在各种患者子组中的好处.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘往往具有重叠的过敏和eosinophilic表型.
- 这些表型的患者可能是抗eosinophilic或抗免疫球蛋白E (IgE) 生物药物的候选者.
研究的目的:
- 评估mepolizumab在严重喘患者的现实有效性,这些患者表现出过敏和eosinophilic表型.
- 这项分析使用了来自国际前性REALITI-A研究的一年数据.
主要方法:
- 该研究评估了临床显著喘恶化 (CSE) 发生率在梅波利祖马布治疗前一年和治疗后一年.
- 分层是基于基线总IgE (tIgE) 水平,亚托皮状态,先前使用奥马利祖马布和奥马利祖马布的资格进行的.
- 进一步的分析检查了tIgE水平和血中乙氨基酸细胞计数的组合.
主要成果:
- 梅波利祖马布治疗显著降低了822名患者的CSE发病率,其中49%的患者在治疗后经历了恶化,而治疗前的比例为93%.
- 在所有子组中,CSE率的降低是一致的,包括不同的tIgE水平,亚托皮状态,先前使用奥马利祖马布和符合奥马利祖马布的资格.
- 在所有基线tIgE和血液中氨酸细胞计数的组合中观察到有效性.
结论:
- 梅波利祖马布在减轻严重喘和eosinophilic表型患者的恶化方面表现出显著的现实有效性.
- 这种好处不论是否存在重叠的过敏表型,都会保持不变.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
01:19Antiasthma Drugs: Leukotriene Modifiers
241
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
241
01:20Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
01:24Antiasthma Drugs: Methylxanthines
194
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
194
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:17Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349